Breaking News, Collaborations & Alliances

Novartis Invests in Credence MedSystems

Supporting ramp-up of manufacturing capacity for innovative injectable drug delivery systems.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Drug delivery company Credence MedSystems announced that Novartis has made a strategic investment in the company. The investment will advance ongoing development and scaling of Credence’s innovative drug delivery systems, with an initial focus on the Credence Companion Safety Syringe System.   The Credence Companion allows pharmaceutical manufacturers to provide critical usability and safety features to their end-users. At the completion of the injection, the user receives end-of-dose cues indic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters